Position in DXCM
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$538
-$1,510 QoQ
Shares Held
8
-73.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#947
of 966 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Provenance Wealth Advisors, LLC holds $407,385 across 9 Medical Devices names. DXCM ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,129 | $283,925 | |
| 2 | SYK |
Stryker Corp
|
234 | $73,672 | |
| 3 | MDT |
Medtronic plc
|
485 | $37,941 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
98 | $6,272 | |
| 5 | BSX |
Boston Scientific Corp
|
57 | $2,432 | |
| 6 | ITGR |
Integer Holdings Corp
|
12 | $1,121 | |
| 7 | PODD |
Insulet Corp
|
5 | $761 | |
| 8 | EW |
Edwards Lifesciences Corp
|
8 | $723 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $538 | 8 | Shares | Sole | 2026-07-24 | |
| 2025-03-31 | $2,048 | 30 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $2,333 | 30 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $2,011 | 30 | Shares | Sole | 2025-08-15 | |
| 2024-06-30 | $3,401 | 30 | Shares | Sole | 2025-08-15 | |
| 2024-03-31 | $4,161 | 30 | Shares | Sole | 2025-08-15 | |
| 2023-12-31 | $5,708 | 46 | Shares | Sole | 2025-08-15 | |
| 2023-09-30 | $2,799 | 30 | Shares | Sole | 2025-08-15 | |
| No filing history on record for this holder in this stock. | ||||||